Advertisement

Metaanalysis vs large clinical trials: which should guide our management?

Published:November 25, 2008DOI:https://doi.org/10.1016/j.ajog.2008.09.873
      Large, randomized clinical trials have long been considered the gold standard to guide clinical care. Metaanalysis is a type of analysis in which results of a number of randomized clinical trials are combined and a summary measure of effect for a given treatment is ascertained. The clinician in practice often is faced with a dilemma regarding the type of evidence that should be used to guide clinical practice; for many clinical problems, there are both randomized controlled trials and metaanalyses available. The cases of calcium and aspirin therapy for the prevention of preeclampsia afford an opportunity to explore the benefits and limitations of each type of study to guide clinical practice. We conclude that, when available, large randomized clinical trials should be used to guide clinical practice.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Redman C.W.
        • Sargent I.L.
        Latest advances in understanding pre-eclampsia.
        Science. 2005; 308: 1592-1594
        • Levine R.J.
        • Maynard S.E.
        • Qian C.
        • et al.
        Circulating angiogenic factors and the risk of pre-eclampsia.
        N Engl J Med. 2004; 350: 672-683
        • Bussolino F.
        • Benedetto C.
        • Massobrio M.
        • Camussi G.
        Maternal vascular prostacyclin activity in pre-eclampsia.
        Lancet. 1980; 2: 702
        • Masotti G.
        • Galanti G.
        • Poggesi L.
        • et al.
        Differential inhibition of prostacyclin production and platelet aggregation by aspirin.
        Lancet. 1979; 2: 1213-1217
        • Belizan J.M.
        • Villar J.
        The relationship between calcium intake and edema, proteinuria, and hypertension-gestosis: a hypothesis.
        Am J Clin Nutr. 1980; 33: 2202-2210
        • Belizan J.M.
        • Villar J.
        • Repke J.
        The relationship between calcium intake and pregnancy-induced hypertension: up-to-date evidence.
        Am J Obstet Gynecol. 1988; 1598: 898-902
        • Kincaid-Smith P.
        • North R.A.
        • Fairly K.F.
        • et al.
        Prevention of pre-eclampsia in women with renal disease: a prospective randomized trial of heparin and dipyridamole.
        Nephrology. 1995; 1: 297-300
        • CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group
        CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women.
        Lancet. 1994; 343: 619-629
        • Niromanesh S.
        • Laghii S.
        • Mosavi-Jarrahi A.
        Supplementary calcium in prevention of pre-eclampsia.
        Int J Obstet Gynecol. 2001; 74: 17-21
        • Villar J.
        • Abdel-Aleem H.
        • Merialdi M.
        • et al.
        World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women.
        Am J Obstet Gynecol. 2006; 194: 639-649
        • Sibai B.M.
        • Caritis S.N.
        • Thom E.
        • et al.
        Prevention of pre-eclampsia with low-dose aspirin in healthy, nulliparous pregnant women.
        N Engl J Med. 1993; 329: 1213-1218
        • Caritis S.
        • Sibai B.
        • Hauth J.
        • et al.
        Low-dose aspirin to prevent pre-eclampsia in women at high risk.
        N Engl J Med. 1998; 338: 701-705
        • Golding J.
        A randomized trial of low dose aspirin for primiparae in pregnancy.
        BJOG. 1998; 105: 293-299
        • Rotchell Y.E.
        • Cruickshank J.K.
        • Phillips Gay M.
        • et al.
        Barbados low dose aspiring study in pregnancy (BLASP): a randomized trial for the prevention of pre-eclampsia and its complications.
        BJOG. 1998; 105: 286-292
        • Askey L.M.
        • Duley L.
        • Henderson-Smart D.J.
        • Stewart L.A.
        • PARIS Collaborative Group
        Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
        Lancet. 2007; 369: 1791-1798
        • Duley L.
        • Henderson-Smart D.J.
        • Meher S.
        • King J.F.
        Antiplatelet agents for prevention of pre-eclampsia and its complications.
        Cochrane Database Syst Rev. 2007; (CD004659)
        • Levine R.J.
        • Hauth J.C.
        • Curet L.B.
        • et al.
        Trial of calcium to prevent pre-eclampsia.
        N Engl J Med. 1997; 337: 69-76
        • Hofmeyer G.J.
        • Atallah A.N.
        • Duley L.
        Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.
        Cochrane Database Syst Rev. 2006; (CD001059)
        • Easterbrook P.S.
        • Berlin J.A.
        • Gopalan R.
        • Matthews D.R.
        Publication bias in clinical research.
        Lancet. 1991; 337: 867-872
      1. Higgins J.P.T. Green S. Cochrane handbook for systematic reviews of interventions, version 5.0.0 (updated February 2008): the Cochrane collaboration. 2008 (Available at: www.cochrane-handbook.org. Accessed Aug. 1, 2008.)
        • Stewart L.A.
        • Clard M.J.
        • Cochrane working group on meta-analysis using individual patient data
        Practical methodology of meta-analysis using updated individual patient data.
        Stat Med. 1995; 14: 2057-2079
        • Simmonds M.C.
        • Higgins J.P.
        • Stewart L.A.
        • et al.
        Meta-analysis of individual patient data from randomized trials: a review of methods used in practice.
        Clin Trial. 2005; 2: 209-217
        • Schulz K.F.
        • Chalmers I.
        • Hayes R.J.
        • Altman D.G.
        Empirical estimates of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials.
        JAMA. 1995; 273: 408-412
        • Moher D.
        • Cook D.J.
        • Eastwood S.
        • et al.
        Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement.
        Lancet. 1999; 354: 1896-1900
        • LeLorier J.
        • Gregoire G.
        • Benhaddad A.
        • et al.
        Discrepancies between meta-analysis and subsequent large randomized, controlled trials.
        N Engl J Med. 1997; 337: 536-542